Sign In
Buy ADAG
$3.98
+0.140 (+3.65%)
At Close: Jun 23, 2026
Adagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option
10:08am, Thursday, 11'th Feb 2021
SAN FRANCISCO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene" or the "Company") (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the dis
